GenDx Co-Founder Wietse Mulder Invests $100,000 in AI Transplant Company Immunomatics and Joins as Strategic Advisor
Experienced transplant diagnostics entrepreneur adds strategic backing and industry guidance to Immunomatics and its AI-based approach to transplant donor risk assessment SAN MARCOS, Calif., Oct. 7, 2026 /PRNewswire/ -- Immunomatics, Inc., a healthtech company developing AI-based tools to...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.